150 related articles for article (PubMed ID: 16405560)
1. Leukocytapheresis in ulcerative colitis.
Irving PM
Am J Gastroenterol; 2006 Jan; 101(1):203-4. PubMed ID: 16405560
[No Abstract] [Full Text] [Related]
2. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis?
Jo Y; Matsumoto T; Mibu R; Iida M
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S3-9. PubMed ID: 14530652
[TBL] [Abstract][Full Text] [Related]
3. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
[TBL] [Abstract][Full Text] [Related]
5. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.
Sawada K; Kusugami K; Suzuki Y; Bamba T; Munakata A; Hibi T; Shimoyama T
Am J Gastroenterol; 2005 Jun; 100(6):1362-9. PubMed ID: 15929771
[TBL] [Abstract][Full Text] [Related]
6. Leukocytapheresis for the treatment of IBD.
Sigurbjörnsson FT; Bjarnason I
Nat Clin Pract Gastroenterol Hepatol; 2008 Sep; 5(9):509-16. PubMed ID: 18665138
[TBL] [Abstract][Full Text] [Related]
7. Centrifugal leukocytapheresis therapy for ulcerative colitis without concurrent corticosteroid administration.
Okada H; Takenaka R; Hiraoka S; Makidono C; Hori S; Kato J; Okazaki H; Kawamoto H; Mizuno M; Shiratori Y
Ther Apher Dial; 2006 Jun; 10(3):242-6. PubMed ID: 16817788
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of five days of consecutive leukocytapheresis for the treatment of ulcerative colitis: a preliminary study.
Tsujikawa T; Andoh A; Ogaẃa A; Sonoda A; Yagi Y; Hata K; Sasaki M; Saito Y; Fujiyama Y
Ther Apher Dial; 2009 Feb; 13(1):14-8. PubMed ID: 19379165
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitis.
Shimada M; Iwase H; Tsuzuki T; Hirashima N; Kobayashi K; Hibino Y; Watanabe H; Ryuge N; Ando T; Goto H; Yagi Y; Tsujikawa T; Andoh A
Ther Apher Dial; 2008 Oct; 12(5):368-73. PubMed ID: 18937719
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of granulocytapheresis for the treatment of active ulcerative colitis and avoidance of systemic corticosteroid administration.
Tokoro C; Inamori M; Uchiyama T; Iida H; Endo H; Hosono K; Sakamoto Y; Takahashi H; Koide T; Goto A; Yasuzaki H; Abe Y; Matsuda R; Takahashi D; Kawana I; Suzuki S; Nakajima A
Digestion; 2010; 82(1):37-8. PubMed ID: 20185918
[No Abstract] [Full Text] [Related]
12. Leukocytapheresis in a girl with severe ulcerative colitis refractory to corticosteroids, infliximab, and cyclosporine A.
Dittrich K; Richter M; Rascher W; Köhler H
Inflamm Bowel Dis; 2008 Oct; 14(10):1466-7. PubMed ID: 18421764
[No Abstract] [Full Text] [Related]
13. Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients.
Takemoto K; Kato J; Kuriyama M; Nawa T; Kurome M; Okada H; Sakaguchi K; Shiratori Y
Dig Liver Dis; 2007 May; 39(5):422-9. PubMed ID: 17379587
[TBL] [Abstract][Full Text] [Related]
14. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
15. Ratio of platelet reduction is an early predictive factor for the effectiveness of leukocytapheresis for ulcerative colitis patients.
Takemoto K; Kuriyama M; Kato J; Suzuki H; Ishikawa S; Hiraoka S; Yamamoto K
Ther Apher Dial; 2009 Feb; 13(1):6-13. PubMed ID: 19379164
[TBL] [Abstract][Full Text] [Related]
16. Serum Cytokine Profiling of Leukocytapheresis in Pediatric Ulcerative Colitis.
Kashiwagi Y; Go S; Kinjo N; Nishimata S; Kawashima H
Ther Apher Dial; 2015 Aug; 19(4):413-5. PubMed ID: 25807968
[No Abstract] [Full Text] [Related]
17. Useful endoscopic findings for early diagnosis of ulcerative colitis associated colorectal cancer.
Sato Y; Takagi S; Aizawa H; Yokoyama H; Takahashi S; Kakuta Y; Tosa M; Mochida A; Nomura E; Takahashi S; Kinouchi Y; Shimosegawa T
Endoscopy; 2008 Sep; 40 Suppl 2():E71-2. PubMed ID: 18633889
[No Abstract] [Full Text] [Related]
18. Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial.
Emmrich J; Petermann S; Nowak D; Beutner I; Brock P; Klingel R; Mausfeld-Lafdhiya P; Liebe S; Ramlow W
Dig Dis Sci; 2007 Sep; 52(9):2044-53. PubMed ID: 17410456
[TBL] [Abstract][Full Text] [Related]
19. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
Miehlke S; Madisch A; Karimi D; Wonschik S; Kuhlisch E; Beckmann R; Morgner A; Mueller R; Greinwald R; Seitz G; Baretton G; Stolte M
Gastroenterology; 2009 Jun; 136(7):2092-100. PubMed ID: 19303012
[TBL] [Abstract][Full Text] [Related]
20. Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment.
Bresci G; Parisi G; Capria A
Colorectal Dis; 2008 Oct; 10(8):814-7. PubMed ID: 18834420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
